These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33928533)

  • 1. Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia.
    Macina D; Evans KE
    Infect Dis Ther; 2021 Sep; 10(3):1115-1140. PubMed ID: 33928533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in the Middle East.
    Macina D; Evans KE
    Infect Dis Ther; 2021 Jun; 10(2):719-738. PubMed ID: 33905101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Africa.
    Macina D; Evans KE
    Infect Dis Ther; 2021 Sep; 10(3):1097-1113. PubMed ID: 33881713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe.
    Macina D; Evans KE
    Infect Dis Ther; 2021 Dec; 10(4):2071-2118. PubMed ID: 34435338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.
    Scott LJ
    Paediatr Drugs; 2011 Apr; 13(2):133-5. PubMed ID: 21351814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010-2020.
    Bahar E; Shamarina D; Sergerie Y; Mukherjee P
    Infect Dis Ther; 2022 Oct; 11(5):1821-1838. PubMed ID: 35793057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
    McCormack PL
    Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmentally and occupationally acquired diseases in adolescents and adulthood: control of diphtheria, tetanus, pertussis, and poliomyelitis through regular booster vaccinations--a European perspective.
    Hofmann F
    Rev Environ Health; 2005; 20(4):303-17. PubMed ID: 16422349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic considerations for pertussis booster vaccination in adolescents.
    Hay JW; Ward JI
    Pediatr Infect Dis J; 2005 Jun; 24(6 Suppl):S127-33. PubMed ID: 15931140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents.
    Son S; Thamlikitkul V; Chokephaibulkit K; Perera J; Jayatilleke K; Hsueh PR; Lu CY; Balaji V; Moriuchi H; Nakashima Y; Lu M; Yang Y; Yao K; Kim SH; Song JH; Kim S; Kim MJ; Heininger U; Chiu CH; Kim YJ
    Clin Microbiol Infect; 2019 Feb; 25(2):250.e1-250.e7. PubMed ID: 29689428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan.
    Lu CY; Tsai HC; Huang YC; Huang DT; Liu CC; Huang LM;
    Pediatr Infect Dis J; 2017 Dec; 36(12):e307-e312. PubMed ID: 28737625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the burden of pertussis in South Korea.
    Mungall BA; Kim H; Oh KB
    Hum Vaccin Immunother; 2021 Jun; 17(6):1747-1756. PubMed ID: 33412085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges.
    Thisyakorn U; Tantawichien T; Thisyakorn C; Buchy P
    Int J Infect Dis; 2019 Oct; 87():75-83. PubMed ID: 31369823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
    Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
    Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against pertussis in adolescents and adults.
    Esposito S; Principi N;
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S89-S95. PubMed ID: 27130670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations.
    Heininger U; Cherry JD
    Expert Opin Biol Ther; 2006 Jul; 6(7):685-97. PubMed ID: 16805708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent and adult pertussis: disease burden and prevention.
    Edwards K; Freeman DM
    Curr Opin Pediatr; 2006 Feb; 18(1):77-80. PubMed ID: 16470167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of pertussis in Germany: past and present.
    Hellenbrand W; Beier D; Jensen E; Littmann M; Meyer C; Oppermann H; Wirsing von König CH; Reiter S
    BMC Infect Dis; 2009 Feb; 9():22. PubMed ID: 19243604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.